Adaptive Biotechnologies ADPT
NASDAQ ADPT
$23.95 -0.07 (-0.29%)
At close: Oct 19, 2026 · 4:00 PM EDT

Adaptive Biotechnologies (ADPT) Capital Leases (2019)

Updated

Adaptive Biotechnologies' Capital Leases came in at $36.61 million for Q4 2019, up 56.1% from the prior quarter.

Analysis

Adaptive Biotechnologies (ADPT) Capital Leases (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn
5 Tenet Healthcare 22.29 Bn 11.30 Bn -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn
10 Adaptive Biotechnologies 3.82 Bn 2.82 Bn 51.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 36.61 Mn
Sep 30, 2019 23.45 Mn
API Access

Adaptive Biotechnologies Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ADPT&period=max&api_key=YOUR_API_KEY